Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chromium picolinate in non-alcoholic fatty liver disease
IRCT20100123003140N15Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of chromium picolinate in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Tabriz University of Medical Sciences. Started Jan 2018; status: completed.
02
Drugs
chromium picolinate
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on IRCT20100123003140N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100123003140N15.